Ledger.Open graph →
SEC Form D · filed July 17, 2020

Amunix Pharmaceuticals, Inc

Offering
$2.6M
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MOUNTAIN VIEW, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Stuart Peterson · Austin, TXDirectorAndrea Barthwell · Bethesda, MDExecSerena Kim · Bethesda, MDDirectorDavid Hirsch · Mountain View, CADirectorCharles E. Harrell · PORTLAND, ORDirectorJames Brush · Mountain View, CADirectorVolker Schellenberger · Mountain View, CAExecOtello Stampacchia · Mountain View, CADirectorBrent C. Adam · PORTLAND, ORExec · DirectorAngie You · Mountain View, CAExec · DirectorGuido Mallmann · Buenos Aires, C1DirectorDaniel Sundheim · New York, NYDirectorBrandon Nielson · Salt Lake City, UTDirectorFrank Levinson · SAN MATEO, CADirectorTodd J. Bazemore · Lexington, MADirectorJohn Earl · Salt Lake City, UTExec · DirectorJulia Davourie · SAN MATEO, CAExecJames Topper · Mountain View, CADirectorRichard Heyman · Mountain View, CADirectorMonika Garg · Rancho Santa Fe, CADirectorAnthony J. Bash · PORTLAND, ORDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗